Dr. Sagar Lonial, MD
Claim this profileThe Winship Cancer Institute of Emory University
Studies Multiple Myeloma
Studies Plasma Cell Neoplasms
10 reported clinical trials
20 drugs studied
Area of expertise
1Multiple Myeloma
t(4;14) positive
GOF mutation in MMSET positive
2Plasma Cell Neoplasms
t(4;14) positive
GOF mutation in MMSET positive
Affiliated Hospitals
Clinical Trials Sagar Lonial, MD is currently running
CFT7455
for Lymphoma
The purpose of this study is to characterize the safety, tolerability, pharmacokinetics, pharmacodynamics, and antitumor activity of oral cemsidomide (also known as CFT7455) administered at different dosages in subjects with Relapsed/Refractory (r/r) Non-Hodgkin's Lymphoma (NHL) or Multiple Myeloma (MM). Cemsidomide may be administered as a single agent and, in MM only, in combination with oral dexamethasone.
Recruiting1 award Phase 1 & 210 criteria
Iberdomide + Daratumumab vs. Bortezomib
for Multiple Myeloma
This is a multicenter, two-stage, randomized, controlled, open-label, Phase 3 study comparing the efficacy and safety of iberdomide in combination with dexamethasone and daratumumab (IberDd) versus daratumumab, bortezomib, and dexamethasone (DVd) in participants with relapsed or refractory multiple myeloma (RRMM).
Recruiting2 awards Phase 3
More about Sagar Lonial, MD
Clinical Trial Related3 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Sagar Lonial, MD has experience with
- Dexamethasone
- Bortezomib
- Iberdomide
- CC-220
- BB2121
- Pomalidomide
Breakdown of trials Sagar Lonial, MD has run
Multiple Myeloma
Plasma Cell Neoplasms
Chronic B-Cell Leukemia
Chronic Lymphocytic Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sagar Lonial, MD specialize in?
Sagar Lonial, MD focuses on Multiple Myeloma and Plasma Cell Neoplasms. In particular, much of their work with Multiple Myeloma has involved t(4;14) positive patients, or patients who are GOF mutation in MMSET positive.
Is Sagar Lonial, MD currently recruiting for clinical trials?
Yes, Sagar Lonial, MD is currently recruiting for 4 clinical trials in Atlanta Georgia. If you're interested in participating, you should apply.
Are there any treatments that Sagar Lonial, MD has studied deeply?
Yes, Sagar Lonial, MD has studied treatments such as Dexamethasone, Bortezomib, Iberdomide.
What is the best way to schedule an appointment with Sagar Lonial, MD?
Apply for one of the trials that Sagar Lonial, MD is conducting.
What is the office address of Sagar Lonial, MD?
The office of Sagar Lonial, MD is located at: The Winship Cancer Institute of Emory University, Atlanta, Georgia 30322 United States. This is the address for their practice at the The Winship Cancer Institute of Emory University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.